Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 01-Nov-2017
No. of pages: 70
Price : Single User: US $ 5750  US $ 4600 Corporate User: US $ 17250  US $ 10350
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Pulmonary Arterial Hypertension - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Pulmonary Arterial Hypertension for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Pulmonary Arterial Hypertension . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Pulmonary Arterial Hypertension for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Pulmonary Arterial Hypertension market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Pulmonary Arterial Hypertension , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Pulmonary Arterial Hypertension for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Pulmonary Arterial Hypertension 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Pulmonary Arterial Hypertension market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

- Understanding historical and forecasted epidemiological data for Pulmonary Arterial Hypertension covering 7MM from 2015-2025.

- Segment level epidemiology and market split for Pulmonary Arterial Hypertension .

- The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Pulmonary Arterial Hypertension .

- The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Pulmonary Arterial Hypertension market trends.

- Thorough market distribution based on market share for Pulmonary Arterial Hypertension .

Reasons to buy

- The report will help in developing business strategies by understanding trends shaping and driving the Pulmonary Arterial Hypertension market.

- To understand the future market competition in the Pulmonary Arterial Hypertension market and Insightful review of the key market drivers and barriers.

- Organize sales and marketing efforts by identifying the best opportunities for Pulmonary Arterial Hypertension in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

- Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction
2. Pulmonary Arterial Hypertension Market Overview at a Glance
2.1. Total Market Share Distribution of Pulmonary Arterial Hypertension for 7 MM in 2016
2.2. Total Market Share Distribution of Pulmonary Arterial Hypertension for 7 MM in 2025
3. Pulmonary Arterial Hypertension
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment
4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Pulmonary Arterial Hypertension in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Pulmonary Arterial Hypertension in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Pulmonary Arterial Hypertension in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Pulmonary Arterial Hypertension in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Pulmonary Arterial Hypertension in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Pulmonary Arterial Hypertension in United Kingdom
5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices
6. Marketed Drugs for Pulmonary Arterial Hypertension
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status
7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase
8. Overview of Total Pulmonary Arterial Hypertension Market (2016 & 2025)
9. Pulmonary Arterial Hypertension : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)
10. Market Drivers
11. Market Restraints
12. Appendix
13. Report Methodology
14. Consulting Services
15. Disclaimer
16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Pulmonary Arterial Hypertension in United States (2015-2025)
Table 2: Diagnosed Cases Pulmonary Arterial Hypertension in Germany (2015-2025)
Table 3: Diagnosed Cases Pulmonary Arterial Hypertension in France (2015-2025)
Table 4: Diagnosed Cases Pulmonary Arterial Hypertension in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Pulmonary Arterial Hypertension in Spain (2015-2025)
Table 6: Diagnosed Cases Pulmonary Arterial Hypertension in Italy (2015-2025)
Table 7: Diagnosed Cases Pulmonary Arterial Hypertension in Japan (2015-2025)
Table 8: List of Marketed Drugs for Pulmonary Arterial Hypertension
Table 9: List of Pipeline Phase III Drugs for Pulmonary Arterial Hypertension
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 17: Germany Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 18: France Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 20: Spain Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 21: Italy Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Table 22: Japan Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Pulmonary Arterial Hypertension in United States (2015-2025)
Figure 2: Diagnosed Cases Pulmonary Arterial Hypertension in Germany (2015-2025)
Figure 3: Diagnosed Cases Pulmonary Arterial Hypertension in France (2015-2025)
Figure 4: Diagnosed Cases Pulmonary Arterial Hypertension in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Pulmonary Arterial Hypertension in Spain (2015-2025)
Figure 6: Diagnosed Cases Pulmonary Arterial Hypertension in Italy (2015-2025)
Figure 7: Diagnosed Cases Pulmonary Arterial Hypertension in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Pulmonary Arterial Hypertension
Figure 9: List of Pipeline Phase III Drugs for Pulmonary Arterial Hypertension
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 17: Germany Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 18: France Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 20: Spain Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 21: Italy Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)
Figure 22: Japan Market Size of Pulmonary Arterial Hypertension in USD, Million (2015-2025)

  • Global Lercanidipine (API) Market Outlook 2017-2022
    Published: 08-Nov-2017        Price: US 2800 Onwards        Pages: 99
    Lercanidipine is an antihypertensive (blood pressure lowering) drug. It belongs to the dihydropyridine class of calcium channel blockers, which work by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body. This lowers the blood pressure and allows the heart to work more efficiently. Lercanidipine is used for the treatment of essential hypertension (high blood pressure). The report covers forecast and analysis for the lercanidipine mark......
  • Pulmonary Arterial Hypertension - Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Pulmonary Arterial Hypertension -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Pulmonary Arterial Hypertension in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Pulmonary Arterial Hypertension. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Pulmonary Arterial Hypert......
  • Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2250 Onwards        Pages: 120
    DelveInsight's, Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Pulmonary Arterial Hypertension. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for P......
  • Global Hypertension Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandi......
  • Portal Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Portal Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Portal Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Portal Hypertension by development stage, therapy type, route of administration and molecule type is also covered in the report. I......
  • Pulmonary Arterial Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 70
    DelveInsight's, "Pulmonary Arterial Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Pulmonary Arterial Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Pulmonary Arterial Hypertension by development stage, therapy type, route of administration and molecule t......
  • Anti-hypertension -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Anti-hypertension - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Anti-hypertension in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Anti-hypertension prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with th......
  • Resistant Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Resistant Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Resistant Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Resistant Hypertension by development stage, therapy type, route of administration and molecule type is also covered in the ......
  • Anti-hypertension - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Anti-hypertension - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Anti-hypertension - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs